
Minimally Invasive Treatment + Modified Radical Mastectomy, The First Choice of Early-stage Breast Cancer*
On Jan. 22, 2015, the series report of Modern Cancer Hospital Guangzhou, Breast Cancer Is Not Incurable, was published on Nanyang Siang Pau. Farida Islam, Bengalese who was diagnosed with stage II breast cancer successfully discharged after receiving minimally invasive treatment as well as modified radical mastectomy in Modern Cancer Hospital Guangzhou.
Farida Islam was diagnosed with breast cancer on Oct. 27, 2014. Thanks to early detection, it was still in an early stage (right breast infiltrating ductal carcinoma, stage II), so the curative ratio was very high. She followed her relatives’ advice and came to Modern Cancer Hospital Guangzhou for treatment. The first interventional therapy was very successful and she didn’t feel any discomfort. Then she followed doctor’s advice and took modified radical mastectomy which the doctor said was a good choice for her because there was still no deterioration or metastasis in her cancer. Although there was slight side effect, Farida Islam thought it was bearable and she recovered very soon under the attentive care of medical staffs and her husband. She discharged from the hospital on Dec. 26.
It is generally known that breast cancer is a systemic disease. Currently, surgery is still one of the main treatment methods, while other adjuvant therapies include auxiliary chemotherapy, endocrine therapy, immunotherapy, radiotherapy and so on. Surgery is the primary treatment for breast cancer. The main advantage of modified radical mastectomy is to eliminate tumor lesions while preserving pectoralis major, pectoralis minor muscle or just cutting the pectoralis minor muscle. This approach not only reduces the patient’s pain and shortens healing time, but it can better keep patient’s thorax shape and avoid dysfunction in upper arm, which is conducive to breast reconstruction and recovery of motor function. Compared with the traditional surgery, postoperative five or ten year survival rate of modified radical mastectomy can reach to over 90%, with both postoperative survival rate and recurrence rate manifested no significant difference with that of traditional radical mastectomy. Before modified radical mastectomy, minimally invasive therapies such as interventional therapy, cryotherapy and radioactive particle implantation can be performed to the patients to effectively eliminate the local tumors, and create a favorable condition for the surgery. In addition, experts from Modern Cancer Hospital Guangzhou remind all patients that good nursing is the key to ensure a successful surgery, reduce related complications and improve survival rate.
